Table 3.
n | 5-yr OS (%) | MST (mo) | Univariate |
Multivariate |
||
P value | HR (95%CI) | P value | ||||
26 | 28.7 | 14.1 | ||||
Sex | ||||||
Male | 16 | 27.1 | 12.2 | |||
Female | 10 | 25.7 | 16.9 | 0.753 | - | |
Age (yr) | ||||||
< 65 | 10 | 38.1 | 14.1 | |||
≥ 65 | 16 | 0 | 12.2 | 0.483 | - | |
CA 19-9 (U/mL) | ||||||
< 10 | 17 | 35.7 | 16.9 | |||
≥ 10 | 9 | 0 | 12.2 | 0.327 | - | |
CEA (ng/mL) | ||||||
< 3 | 16 | 35.8 | 14.1 | |||
≥ 3 | 10 | 0 | 9.1 | 0.382 | - | |
Tumor location | ||||||
U | 2 | 0 | 8.7 | |||
M and L | 24 | 30.0 | 14.1 | 0.569 | - | |
Histopathological type | ||||||
Differentiated | 10 | 0 | 16.9 | |||
Undifferentiated | 16 | 40.9 | 14.1 | 0.529 | - | |
Venous invasion | ||||||
(-) | 12 | 0 | 14.1 | |||
(+) | 14 | 16.7 | 16.9 | 0.411 | - | |
Lymphatic invasion | ||||||
(-) | 3 | 0 | 9.1 | |||
(+) | 23 | 26.9 | 14.1 | 0.624 | - | |
Tumor size (mm) | ||||||
< 45 | 5 | 0 | 9.1 | |||
≥ 45 | 21 | 31.4 | 14.1 | 0.274 | - | |
T-category | ||||||
T1 and T2 | 3 | 0 | 9.1 | |||
T3 and T4 | 23 | 31.5 | 16.9 | 0.222 | - | |
N-category | ||||||
N1 or N2 | 10 | 62.5 | 16.8 | |||
N3 | 16 | 0 | 8.8 | 0.002 | 5.17 (1.8-292.7) | 0.021 |
OS: Overall survival; MST: Median survival time; CEA: Carcinoembryonic antigen; CA 19-9: Carbohydrate antigen 19-9; U: Upper gastric body; M: Middle gastric body; L: Lower gastric body.